Stem Cell Pink Sheet Forecast - Triple Exponential Smoothing
| SCAL Stock | USD 0.0001 0.00 0.00% |
The Triple Exponential Smoothing forecasted value of Stem Cell Authority on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0.00000167 and the sum of the absolute errors of 0.0001. Stem Pink Sheet Forecast is based on your current time horizon.
As of now the relative strength index (rsi) of Stem Cell's share price is below 20 . This usually implies that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Stem Cell hype-based prediction, you can estimate the value of Stem Cell Authority from the perspective of Stem Cell response to recently generated media hype and the effects of current headlines on its competitors.
The Triple Exponential Smoothing forecasted value of Stem Cell Authority on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0.00000167 and the sum of the absolute errors of 0.0001. Stem Cell after-hype prediction price | USD 1.08E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Stem |
Stem Cell Additional Predictive Modules
Most predictive techniques to examine Stem price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Stem using various technical indicators. When you analyze Stem charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Stem Cell Triple Exponential Smoothing Price Forecast For the 24th of January
Given 90 days horizon, the Triple Exponential Smoothing forecasted value of Stem Cell Authority on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0.00000167, mean absolute percentage error of 0, and the sum of the absolute errors of 0.0001.Please note that although there have been many attempts to predict Stem Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Stem Cell's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stem Cell Pink Sheet Forecast Pattern
| Backtest Stem Cell | Stem Cell Price Prediction | Buy or Sell Advice |
Stem Cell Forecasted Value
In the context of forecasting Stem Cell's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Stem Cell's downside and upside margins for the forecasting period are 0.000001 and 6.30, respectively. We have considered Stem Cell's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Stem Cell pink sheet data series using in forecasting. Note that when a statistical model is used to represent Stem Cell pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0 |
| MAPE | Mean absolute percentage error | 0.0167 |
| SAE | Sum of the absolute errors | 1.0E-4 |
Predictive Modules for Stem Cell
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Stem Cell Authority. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Stem Cell After-Hype Price Prediction Density Analysis
As far as predicting the price of Stem Cell at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Stem Cell or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Stem Cell, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Stem Cell Estimiated After-Hype Price Volatility
In the context of predicting Stem Cell's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Stem Cell's historical news coverage. Stem Cell's after-hype downside and upside margins for the prediction period are 0.00 and 6.30, respectively. We have considered Stem Cell's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Stem Cell is out of control at this time. Analysis and calculation of next after-hype price of Stem Cell Authority is based on 3 months time horizon.
Stem Cell Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Stem Cell is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Stem Cell backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Stem Cell, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.79 | 6.30 | 0.00 | 0.00 | 0 Events / Month | 1 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.0001 | 0.0001 | 8.45 |
|
Stem Cell Hype Timeline
Stem Cell Authority is at this time traded for 0.0001. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Stem is forecasted to increase in value after the next headline, with the price projected to jump to 1.08E-4 or above. The average volatility of media hype impact on the company the price is insignificant. The price upswing on the next news is estimated to be 8.45%, whereas the daily expected return is at this time at -0.79%. The volatility of related hype on Stem Cell is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company has return on total asset (ROA) of 0.4909 % which means that it generated a profit of $0.4909 on every $100 spent on assets. This is way below average. Stem Cell's management efficiency ratios could be used to measure how well Stem Cell manages its routine affairs as well as how well it operates its assets and liabilities. Given the investment horizon of 90 days the next forecasted press release will be within a week. Check out Historical Fundamental Analysis of Stem Cell to cross-verify your projections.Stem Cell Related Hype Analysis
Having access to credible news sources related to Stem Cell's direct competition is more important than ever and may enhance your ability to predict Stem Cell's future price movements. Getting to know how Stem Cell's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Stem Cell may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| HSMD | Healthcare Solutions Management | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CEVE | Ceres Ventures | 0.00 | 5 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ASFX | American Scientf | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MDIT | Medite Cancer Diagnostics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| RCAR | RenovaCare | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| VRAYQ | ViewRay | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SCPS | Scopus Biopharma | 0.00 | 0 per month | 0.00 | 0.09 | 33.33 | (25.00) | 83.33 | |
| LOWLF | Lowell Farms | 0.00 | 2 per month | 19.82 | 0.16 | 70.48 | (36.31) | 1,900 | |
| NUGS | Cannabis Strategic Ventures | 0.00 | 0 per month | 0.00 | 0.14 | 0.00 | 0.00 | 316.67 | |
| PTLF | Petlife Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Forecasting Options for Stem Cell
For every potential investor in Stem, whether a beginner or expert, Stem Cell's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Stem Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Stem. Basic forecasting techniques help filter out the noise by identifying Stem Cell's price trends.Stem Cell Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Stem Cell pink sheet to make a market-neutral strategy. Peer analysis of Stem Cell could also be used in its relative valuation, which is a method of valuing Stem Cell by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Stem Cell Market Strength Events
Market strength indicators help investors to evaluate how Stem Cell pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Stem Cell shares will generate the highest return on investment. By undertsting and applying Stem Cell pink sheet market strength indicators, traders can identify Stem Cell Authority entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
Stem Cell Risk Indicators
The analysis of Stem Cell's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Stem Cell's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting stem pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.49 | |||
| Standard Deviation | 6.15 | |||
| Variance | 37.88 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Stem Cell
The number of cover stories for Stem Cell depends on current market conditions and Stem Cell's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Stem Cell is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Stem Cell's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Other Information on Investing in Stem Pink Sheet
Stem Cell financial ratios help investors to determine whether Stem Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Stem with respect to the benefits of owning Stem Cell security.